Lifeboat Foundation

A team of researchers from the URV and the RMIT University (Australia) has designed and manufactured a surface that uses mechanical means to mitigate the infectious potential of viruses. Made of silicon, the artificial surface consists of a series of tiny spikes that damage the structure of viruses when they come into contact with it. The work is published in the journal ACS Nano.

The research has revealed how these processes work and that they are 96% effective. Using this technology in environments in which there is potentially dangerous biological material would make laboratories easier to control and safer for the professionals who work there.

Spike the viruses to kill them. This seemingly unsophisticated concept requires considerable technical expertise and has one great advantage: a high virucidal potential that does not require the use of chemicals. The process of making the virucidal surfaces starts with a smooth metal plate, which is bombarded with ions to strategically remove material.

Researchers at ETH Zurich have recently developed artificial muscles for robot motion. Their solution offers several advantages over previous technologies: It can be used wherever robots need to be soft rather than rigid or where they need more sensitivity when interacting with their environment.

Many roboticists dream of building robots that are not just a combination of metal or other hard materials and motors but also softer and more adaptable.

Continue reading “Soft artificial muscles developed for robot motion” »

As artificial intelligence technologies such as Chat-GPT are utilized in various industries, the role of high-performance semiconductor devices for processing large amounts of information is becoming increasingly important. Among them, spin memory is attracting attention as a next-generation electronics technology because it is suitable for processing large amounts of information with lower power than silicon semiconductors that are currently mass-produced.

Utilizing recently discovered quantum materials in spin memory is expected to dramatically improve performance by improving signal ratio and reducing power, but to achieve this, it is necessary to develop technologies to control the properties of quantum materials through electrical methods such as current and voltage.

Dr. Jun Woo Choi of the Center for Spintroncs Research at the Korea Institute of Science and Technology (KIST) and Professor Se-Young Park of the Department of Physics at Soongsil University have announced the results of a collaborative study showing that ultra-low-power memory can be fabricated from quantum materials. The findings are published in the journal Nature Communications.

Researchers at the University of Toronto have used an artificial intelligence framework to redesign a crucial protein involved in the delivery of gene therapy.

The study, published in Nature Machine Intelligence, describes new work optimizing proteins to mitigate immune responses, thereby improving the efficacy of gene therapy and reducing side effects.

“Gene therapy holds immense promise, but the body’s pre-existing immune response to viral vectors greatly hampers its success. Our research zeroes in on hexons, a fundamental protein in adenovirus vectors, which—but for the immune problem—hold huge potential for gene therapy,” says Michael Garton, an assistant professor at the Institute of Biomedical Engineering in the Faculty of Applied Science & Engineering.

This is interesting. Who knew brain drain would be helpful? Haha it’s a different context but it’s medicinal in this sense. Amazing discovery!

Estimated read time: 2–3 minutes.

SALT LAKE CITY — Add this to the list of potential targets to treat Alzheimer’s and other neurodegenerative disorders: Researchers in South Korea have discovered a network of lymphatic vessels at the back of the nose that help drain cerebral spinal fluid from the brain.

Continue reading “Brain drain: How nasal and lymphatic drainage discovery could help end Alzheimer’s” »

We are witnessing a professional revolution where the boundaries between man and machine slowly fade away, giving rise to innovative collaboration.

Photo by Mateusz Kitka (Pexels)

As Artificial Intelligence (AI) continues to advance by leaps and bounds, it’s impossible to overlook the profound transformations that this technological revolution is imprinting on the professions of the future. A paradigm shift is underway, redefining not only the nature of work but also how we conceptualize collaboration between humans and machines.

As creator of the ETER9 Project ⁽²⁾, I perceive AI not only as a disruptive force but also as a powerful tool to shape a more efficient, innovative, and inclusive future. As we move forward in this new world, it’s crucial for each of us to contribute to building a professional environment that celebrates the interplay between humanity and technology, where the potential of AI is realized for the benefit of all.

In the ETER9 Project, dedicated to exploring the interaction between artificial intelligences and humans, I have gained unique insights into the transformative potential of AI. Reflecting on the future of professions, it’s evident that adaptability and a profound understanding of technological dynamics will be crucial to navigate this new landscape.

Continue reading “The Professions of the Future (1)” »

While NASA is well-known for advancing various technologies for the purposes of space exploration, whether it’s sending spacecraft to another world or for use onboard the International Space Station (ISS), the little-known fact is that these same technologies can be licensed for commercial use to benefit humankind right here on the Earth through NASA’s Spinoff program, which is part of NASA’s Space Technology Mission Directorate and its Technology Transfer program. This includes fields like communication, medical, weather forecasting, and even the very mattresses we sleep on, and are all featured in NASA’s annual Spinoff book, with NASA’s 2024 Spinoff book being the latest in sharing these technologies with the private sector.

“As NASA’s longest continuously running program, we continue to increase the number of technologies we license year-over-year while streamlining the development path from the government to the commercial sector,” Daniel Lockney, Technology Transfer Program Executive at NASA Headquarters, said in a statement. “These commercialization success stories continually prove the benefits of transitioning agency technologies into private hands, where the real impacts are made.”

One example is a medical-grade smartwatch called EmbracePlus developed by Empatica Inc., which uses machine learning algorithms to monitor a person’s vitals, including sleep patterns, heart rate, and oxygen flow. EmbracePlus reached mass production status in 2021 and has been approved by the U.S. Food and Drug Administration (FDA) with the goal of using the smartwatch for astronauts on future spaceflights, including the upcoming Artemis missions, along with medical patients back on Earth.

Steve P. Miller, PhD, has spent much of his career figuring out how to shut off autoimmune responses when he observed dying cells acting as carriers of autoantigens that could modulate the immune system. More than 20 years ago, while a professor at Northwestern University’s Feinberg School of Medicine, Miller discovered that dendritic cells (DCs), a subtype of antigen-presenting cells (APCs), could be changed or turned off to send the right signals to make immunologically tolerant T cells, also known as “tolerogenic.”

Miller’s attention turned toward investigating how best to mimic the apoptotic cells, overriding the expression of dendritic cells. So, Miller partnered with polymer chemist Lonnie D. Shea, PhD, who was at the McCormick School of Engineering, to develop a nanoparticle that interacts effectively with dendritic cells.

In 2013, Miller and Shea helped launch a company spun out of Northwestern University, when Shea was still in Chicago, called Cour Pharmaceutical Development Company, to develop innovative nanobiological therapeutics for acute inflammation, autoimmune, and allergic conditions. After years of experimentation, they developed a formula for nanoparticles of the right size and charge that interact well with the immune system, which is the foundation for their proprietary antigen-specific immune tolerance platform.

Google’s Bard chatbot is powered by a new Gemini model. Early users rate it as similar to GPT-4.

Google’s head of AI, Jeff Dean, announced the new Gemini model on X. It is a model from the Gemini Pro family with the suffix “scale”

Thanks to the Gemini updates, Bard is “much better” and has “many more capabilities” compared to the launch in March, according to Dean.